Bionik Laboratories (BNKL) Return on Equity ROE from the fourth quarter 2023 to fourth quarter 2022 and annually, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bionik Laboratories Corp   (BNKL)

Bionik Laboratories 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Bionik Laboratories in the fourth quarter 2023?
Due to the lack of equity, it was not possible to calculate Bionik Laboratories Corp 's return on equity (ROE) in its fourth quarter 2023

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2023)
IV. Quarter		 (Dec 31 2022)
III. Quarter		 (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter		 (Mar 31 2022)
IV. Quarter
Y / Y Equity Change - - -77.63 % -45.26 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -5 -5 -11 -11 -10
Return On Equity (TTM) - -468.07 % -7408.19 % -1875.05 % -1113.27 %
BNKL's Total Ranking # # # # #
Equity (TTM) in Millions -2 -1 1 2 3
Seq. Equity Change - - -67.24 % -45.46 % -
Seq. Net Income Change - - - - -

Back to BNKL Management Effectiveness >> BNKL's 5 Years Annual ROE >> Compare BNKL ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





BNKL Annual Return On Equity (Mar 31 2023)
2023		 (Mar 31 2022)
2022		 (Mar 31 2021)
2021		 (Mar 31 2020)
2020		 (Mar 31 2019)
2019
Total Equity in Millions -2 3 3 13 27
Y / Y Equity Change - -10.78 % -75.36 % -51.41 % 33.94 %
Net Income in Millions -5 -10 -14 0 0
Y / Y Net Income Change - - - - -
Return On Equity - -355.56 % -415.13 % 0 % 0 %

Back to BNKL Management Effectiveness >> BNKL's 5 Years Annual ROE >> Compare BNKL ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
BNKL's' Return on Equity at Yahoo Finance
BNKL's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for BNKL's Competitors
Subscribers only: Roe for Bionik Laboratories 's Suppliers
Subscribers only: Return On Equity for BNKL's Customers




Companies with similar Return On Equity at Mar 31 2023, within Healthcare Sector ROE
Dyadic International Inc   20,646.72 %

Date modified: 2026-09-08T15:10:58+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.